Table 1.
Characteristics | Number/Mean/(%)/(Range) |
---|---|
total (number) | 32 |
female/male (number, %) | 12/20 (37.5%/62.5%) |
age (years—mean ± stdd., (range)) | 65.92 ± 9.84 (46–88) |
C-reactive protein (mg/L) | 1.48 ± 1.11 |
medication | |
non-steroidal antiinflammatory drugs | 31 (97%) |
steroids (other than prednisolone) | n.a. |
opioid analgesics | 2 (6.25%) |
biologicals | n.a. |
antihypertensive drugs | 19 (59.3%) |
non-selective beta blockers (β1 and β2) | 0 (0%) |
selective beta blockers (β1) | 8 (25%) |
other (AT1, ACE, CCB) | 11 (34.4%) |
Abbreviation: n.a.—not applicable, stdd.—standard deviation, AT1—angiotensin II type 1 receptor blockers, ACE—Angiotensin converting enzyme (ACE) inhibitors, CCB—calcium channel blockers.